| View Larger Image | Perspectives on Mild Cognitive Impairment (Studies on Neuropsychology, Neurology and Cognition) | Library Bindingby Holly A. Tuokko (Author), David F. Hultsch (Author)
| List Price: | $100.00 | | Price: | $51.53 | | You Save: | $48.47 (48%) | | | Available: | Usually ships in 24 hours |
| | Binding: | Library Binding | | Publisher: | Psychology Press | | Edition: | 1st Edition | | Page Count: | 336 Pages | | Publication Date: | September 14, 2006 | | Sales Rank: | 2,116,844nd |
|
EDITORIAL REVIEWS |
Product Description
Mild Cognitive Impairment (MCI) has been identified as an important clinical transition between normal aging and the early stages of Alzheimer's disease (AD). Since treatments for AD are most likely to be most effective early in the course of the disease, MCI has become a topic of great importance and has been investigated in different populations of interest in many countries. This book brings together these differing perspectives on MCI for the first time. This volume provides a comprehensive resource for clinicians, researchers, and students involved in the study, diagnosis, treatment, and rehabilitation of people with MCI. Clinical investigators initially defined mild cognitive impairment (MCI) as a transitional condition between normal aging and the early stages of Alzheimer’s disease (AD). Because the prevalence of AD increases with age and very large numbers of older adults are affected worldwide, these clinicians saw a pressing need to identify AD as early as possible. It is at this very early stage in the disease course that treatments to slow the progress and control symptoms are likely to be most effective.Since the first introduction of MCI, research interest has grown exponentially, and the utility of the concept has been investigated from a variety of perspectives in different populations of interest (e.g., clinical samples, volunteers, population-based screening) in many different countries. Much variability in findings has resulted. Although it has been acknowledged that the differences observed between samples may be ‘legitimate variations’, there has been no attempt to understand what it is we have learned about MCI (i.e., common features and differences) from each of these perspectives.This book brings together information about MCI in different populations from around the world. Mild Cognitive Impairment will be an important resource for any clinician, researcher, or student involved in the study, detection, treatment, and rehabilitation of people with MCI. |
SIMILAR PRODUCTS |
| A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary
by Esther Strauss (Author), Elisabeth M. S. Sherman (Author), Otfried Spreen (Author)
For the practicing neuropsychologist or researcher, keeping up with the sheer number of newly published or updated tests is a challenge, as is evaluating the utility and psychometric properties of neuropsychological tests in a clinical context. The goal of the third edition of A Compendium of Neuropsychological Tests, a well-established neuropsychology reference text, is twofold. First, the Compendium is intended to serve as a guidebook that provides a comprehensive overview of the essential...
| 
| Geriatric Neuropsychology: Assessment and Intervention
by Deborah K. Attix PhD (Editor), Kathleen A. Welsh-Bohmer Phd (Editor)
This major clinical reference and text is the first volume to systematically address the entire process of neuropsychological assessment and intervention with older adults. The expert editors and contributors detail the current state of knowledge about frequently encountered conditions ranging from mild cognitive impairment to progressive, stable, and reversible dementias. Evidence-based assessment and intervention strategies are described, and specific guidance is provided for linking...
| 
| Mild Cognitive Impairment: Aging to Alzheimer's Disease (Medicine)
by Ronald C. Petersen (Editor)
What are the boundary zones between normal aging and Alzheimer's disease (AD)? Are many elderly people whom we regard as normal actually in the early stages of AD? Alzheimer's disease does not develop overnight; the early phases may last for years or even decades. Recently, clinical investigators have identified a transitional condition between normal aging and and very early Alzheimer's disease that they have called mild cognitive impairment, or MCI. This term typically refers to memory...
|
|
|
